Jubilant Pharmova has informed about completion of USFDA audit of Solid dosage manufacturing facility at Roorkee plant pursuant to Provisions of Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.
The above information is a part of company’s filings submitted to BSE.